The psychosocial impact of psoriasis;El impacto psicosocial de la psoriasis

Actas Dermo-Sifiliograficas

Volumn 94, Issue 1, 2003, Pages 11-16

  Sánchez Regaña, Manuel ^a   Ojeda Cuchillero, Rosa ^b   Umbert Millet, Ignacio ^b   Umbert Millet, Pablo ^b   Lupo, Walter ^b   Solé Fernández, Javier ^b  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^b NONE

Author keywords

Impact; Psoriasis; Psychis; Social; Stress

Indexed keywords

ADULT; ARTICLE; DISEASE EXACERBATION; FEMALE; HUMAN; MALE; MENTAL STRESS; MOOD DISORDER; PATIENT SATISFACTION; PSORIASIS; RISK FACTOR; SOCIAL PSYCHOLOGY; SUNBURN;

EID: 0037503926     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(03)79182-0     Document Type: Article

References (33)

1. Ferrándiz C, Bordas X, García-Patos V, Puig S, Pujol R, Smandio A. Prevalence of psoriasis in Spain (Epiderma Project: phase I) JEADV 2001;15:20-3.
2. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985;13:450-6.
3. Baker BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992;126:1-9.
4. Farber EM, Bright R, Nall ML. Psoriasis: a questionnaire survey of 2144 patients. Arch Dermatol 1968;98:248-59.
5. Seville RH. Psoriasis and stress. Br J Dermatol 1977;97:297-302.
6. Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974;148:1-18.
7. Fava GA, Perini GI, Santonastaso P, Fornasa CV. Life events and psychological stress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980;53:277-82.
8. Gaston L, Crombez J, Lassonde M, Bernier-Buzzanga J, Hodgins S. Psychological stress and psoriasis: experimental and prospective correlational studies. Acta Derm Venereol (Stockh) 1991;156:37-43.
9. Mazzetti M, Mozzetta A, Soavi GC, Andreoli E, Foglio Bonda PG, Puddu P, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol Suppl (Stockh) 1994;186:62-4.
10. Polenghi MM, Gala C, Citeri A, Manca G, Gruzzi R, Barcella M, et al. Psychoneurophysiological implications in the pathogenesis and treatment of psoriasis. Acta Derm Venereol Suppl (Stockh) 1989;146:84-6.
11. Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized exposure. Psychosom Med 1985;47:528-41.
12. Ginsburg IH, Link BG. Feelings of stimatization in patients with psoriasis. J Am Acad Dermatol 1989;20:53-63.
13. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988;118:195-201.
14. Gupta MA, Gupta AK. The Psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995;75:240-3.
15. Harvima RJ, Viinamäki H, Harvima IT, Naukkarinen A, Savolainen L, Aalto ML, et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol (Stockh) 1996;76:467-71.
16. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis specific stress. Br J Dermatol 1997;137:755-60.
17. Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-6.
18. Gupta MA, Gupta AK, Watteel GN. Early onset (<40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: A study of 137 patients. Acta Derm Venereol (Stockh) 1996;76:464-6.
19. Farber EM, Lanigan SW, Boer J. The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol 1990;29:418-20.
20. Ansel JC, Kaynard AH, Armstrong CA, Olerud J, Bunnett N, Payan D. Skin-nervous system interactions. J Invest Dermatol 1996;106:198-204.
21. Misery L. Skin, immunity and the nervous system. Br J Dermatol 1997;137:843-50.
22. Farber EM. Psychoneuroimmunology and Dermatology. Int J Dermatol 1993;32:93-4.
23. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-14.
24. Schmid-Ott G, Jaeger B, Kuensebeck HW, Ott R, Lamprecht F. Dimensions of stigmatization in patients with psoriasis in a «questionnaire on experience with skin complaints». Dermatology 1996;193:304-10.
25. Lewis-Jones MS, Finlay AY, Dykes PJ. The infants' dermatitis quality of life index. Br J Dermatol 2001;144:104-10.
26. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life. Arch Dermatol 2001;137:280-4.
27. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 1999;141:1067-75.
28. Cerimele D, Tulli A, Rauco M. Valutazione dell'efficacia e tollerabilità del clotiazepam nella terapia della componente ansiosa di pazienti psoriasici. G Ital Dermatol Venereol 1993;128:31-6.
29. Alpsoy E, Özcan E, Cetin L, Ozgur O, Er H, Yilmaz E, et al. Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? J Am Acad Dermatol 1998;38:197-200.
30. Price ML, Mottahedin I, Mayo PR. Can psychotherapy help patients with psoriasis. Clin Exp Dermatol 1991;16:114-7.
31. Ferrándiz C, Bielsa I, Ribera M, Fuente MJ, Carrascosa JM, et al. Terapia de refuerzo en pacientes con psoriasis tratada con calcipotriol. Actas Dermosifiliogr 1998;89:626-30.
32. Weigl BA. The significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasis. Int J Dermatol 2000;39:678-88.
33. Glinski W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994;131:260-4.